C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
4.470
+0.100 (2.29%)
Jun 1, 2026, 10:09 AM EDT - Market open
C4 Therapeutics Employees
C4 Therapeutics had 104 employees as of December 31, 2025. The number of employees decreased by 6 or -5.45% compared to the previous year.
Employees
104
Change (1Y)
-6
Growth (1Y)
-5.45%
Revenue / Employee
$335,202
Profits / Employee
-$998,087
Market Cap
492.51M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 104 | -6 | -5.45% |
| Dec 31, 2024 | 110 | -35 | -24.14% |
| Dec 31, 2023 | 145 | -1 | -0.68% |
| Dec 31, 2022 | 146 | 25 | 20.66% |
| Dec 31, 2021 | 121 | 22 | 22.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Sutro Biopharma | 137 |
| Ocugen | 116 |
| Adlai Nortye | 109 |
| Upstream Bio | 75 |
| Fulcrum Therapeutics | 55 |
| Contineum Therapeutics | 51 |
| Eupraxia Pharmaceuticals | 49 |
CCCC News
- 2 days ago - C4 Therapeutics jumps after Bristol Myers myeloma data - TheFly
- 5 days ago - C4 Therapeutics Transcript: 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA - Transcripts
- 12 days ago - C4 Therapeutics to Participate in Upcoming Conferences - GlobeNewsWire
- 13 days ago - C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 20 days ago - C4 Therapeutics reports Q1 EPS (20c), consensus (26c) - TheFly
- 20 days ago - C4 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 20 days ago - C4 Therapeutics Quarterly report: Q1 2026 - Filings
- 20 days ago - C4 Therapeutics Earnings release: Q1 2026 - Filings